Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.18 USD | 0.00% | +0.93% | -68.95% |
06:44pm | TFF Pharmaceuticals, Leidos to Advance Biodefense Countermeasures Into Preclinical Testing | MT |
20/05 | TFF Pharmaceuticals Advances Influenza Vaccine Candidates Into Preclinical Testing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-68.95% | 67.54L | |
+64.21% | 6.26TCr | |
-1.73% | 4.12TCr | |
+44.76% | 4.03TCr | |
-8.93% | 2.79TCr | |
+12.75% | 2.62TCr | |
-21.75% | 1.91TCr | |
+4.42% | 1.31TCr | |
+25.73% | 1.23TCr | |
+28.27% | 1.21TCr |
- Stock Market
- Equities
- TFFP Stock
- News TFF Pharmaceuticals, Inc.
- TFF Pharmaceuticals : HC Wainwright Starts TFF Pharmaceuticals at Buy With $31 Price Target